Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armor Proteins is a biotechnology company dedicated to developing a new class of therapeutic proteins with significantly enhanced stability and durability. The company utilizes its proprietary 'Protein Armor' technology to engineer proteins that are resistant to degradation by proteases and extreme physiological conditions, addressing a major limitation in protein therapeutics. By creating these 'armored' versions of bioactive molecules, Armor Proteins aims to improve drug half-life, reduce dosing frequency, and enable alternative delivery routes such as oral administration. Their current research focus spans inflammatory, autoimmune, and metabolic conditions where stabilized protein signaling can provide superior clinical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armor Proteins.